RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021
Renalytix plc - American Depositary Shares (RNLX)
Company Research
Source: GlobeNewswire
NEW YORK, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter ended September 30, 2020. Recent Highlights Launched KidneyIntelX within the Mount Sinai Health SystemSubmitted final package to FDA seeking clearance of KidneyIntelXAnnounced collaboration with AstraZeneca to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseasesCompleted spin-out of Verici Dx (previously FractalDx)Achieved dual listing on Nasdaq Global Market First Quarter 2021 Financial ResultsOperating expense for the three months ended September 30, 2020 was $5.4 million compared to $2.0 million during the prior year period. Research and development expenses were 1.7 million for the three months ended Septembe
Show less
Read more
Impact Snapshot
Event Time:
RNLX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RNLX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RNLX alerts
High impacting Renalytix plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
RNLX
News
- Renalytix Announces Financing with Expected Size of up to $4 MillionGlobeNewswire
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) [Yahoo! Finance]Yahoo! Finance
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)GlobeNewswire
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024GlobeNewswire
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewswire
RNLX
Sec Filings
- 4/23/24 - Form 8-K
- 4/17/24 - Form S-3
- 4/10/24 - Form 8-K
- RNLX's page on the SEC website